The News Scroll 04 August 2020  Last Updated at 3:31 pm | Source: PTI

Lupin gets USFDA nod for generic diabetes drug

Lupin gets USFDA nod for generic diabetes drug
outlookindia.com
1970-01-01T05:30:00+0530
New Delhi, Aug 4 (PTI) Drug maker Lupin on Tuesday said it has received approval from the US health regulator to market a generic diabetes drug in America.

The Mumbai-based company has received a tentative approval from the US Food and Drug Administration (USFDA) for its Empagliflozin tablets, in strengths of 10 mg and 25 mg, Lupin said in a statement.

The product is a generic version of Boehringer Ingelheim Pharmaceuticals, Inc''s Jardiance tablets which are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

As per IQVIA MAT March 2020 data, the drug had an annual sales of around USD 4,368 million in the US. PTI MSS ANU ANU


Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: PTI
Next Story : Passenger transport entities urge Maha govt to provide relief package for school bus operators
Download the Outlook ​Magazines App. Six magazines, wherever you go! Play Store and App Store